Recent Articles By The Author
The administration will provide increased financial support to 5 pharmas working on Covid vaccines, and we must keep an eye on price action in this uncertain market.
I wouldn't mind owning the shares, and they do yield 2.7%.
The market continues to rise despite numerous negative catalysts, while Zoom beat all earnings expectations and guided higher.
We've had quite a run, and I hate to violate net basis, which is a long, long way off.
Taking a chunk of Pfizer during this selloff, while Amazon has raised $10 billion in mixed-maturity debt and all eyes are on the government's response to civil unrest in the U.S.
Let's hope that the violence subsides, the valid voices of peaceful protesters are heard, and the lack of social distancing protocols does not lead to a resurgence in the spread of the virus.
I can comfortably add to CRM should this selloff become severe, and I think that's what I want to do.
As the president's press conference on China approaches, there is ample reason for some risk-off behavior. Meantime, Zscaler's earnings beat is a good time to take a profit.
I'll be taking at least a third of my long off ahead of the numbers this afternoon.